France Aesthetic Medicine Market- Growth, Trends, and Forecast (2020 - 2025)

The France Aesthetic Medicine Market has been segmented by Product (Botulinum Toxin, Dermal Filler, Chemical Peel, and Microdermabrasion) and End User

Market Snapshot

Study Period:


Base Year:


Major Players:

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Market Overview

The key factors propelling the growth of the market are the growing adoption of non-invasive aesthetic procedures, increasing awareness among customers, and availability of user-friendly aesthetic products.

In France, it has been observed that patients begin anti-ageing techniques and minimally invasive treatments at a very young age, and require more invasive procedures in order to maintain their youthful appearance. Moreover, the rise in disposable income has boosted the demand for cosmetic surgeries, thereby accelerating the market growth.

Along with the increased awareness about the potential benefits of aesthetic procedures, people are also inclined toward the use of minimal or non-invasive procedures in aesthetic treatments. The popularity of non-invasive or minimally invasive techniques is increasing in France. The reason for significant inclination is that the majority of the audiences perceive normal surgical treatments as painful and involved with a high risk factors. Thus, the growing adoption of non- or minimally invasive aesthetic procedures is fueling the growth of the medical aesthetic medicine market in France.

Additionally, there has also been an abundant rise in the advertising, displaying the ‘before’ and ‘after’ difference of various aesthetic procedures, thereby prompting the youth and middle aged to undergo medical aesthetic procedures.

Scope of the Report

As per the scope of the report, aesthetic medicine is defined as the specialties that focus on enhancing cosmetic appearance through the treatment of ageing, infectious, or diseased skin conditions. Aesthetic medicines and cosmetic surgery is a developing clinical subspecialty and field in scientific research, which comprises all kind of medical procedures whose purpose is to improve the physical appearance and satisfaction of the patient, including all non-invasive and minimally invasive cosmetic procedures.

By Product
Botulinum Toxin
Dermal Filler
Absorbable Dermal Filler
Non-absorbable Dermal Filler
Chemical Peel
By End User
Office Facilities
Other End Users

Report scope can be customized per your requirements. Click here.

Key Market Trends

Dermal Filler is the Segment by Product that is Expected to Grow the Largest During the Forecast Period

The dermal filler segment has the largest market share, and is expected to continue during the forecast period. The dermal fillers segment is constantly developing in France, and accounts for a sales volume of around 850,000 dermal syringes annually. Absorbable dermal fillers are majorly contributing to the total dermal filler market segment in France, due to its less side effects. On the other hand, the agencies in France are currently not advising the use of non-absorbable products for aesthetic purpose, given the risk of extremely delayed, uncontrollable, and serious adverse effects.

To understand key trends, Download Sample Report

Competitive Landscape

The French aesthetic medicine market is medium consolidated, with some local players competing with international players. The major strategies adopted by most of the key industry players include the new product launches, acquisitions, mergers, and partnerships to strengthen the aesthetics product portfolio and maintain their market position.  

Table Of Contents


    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Growing Adoption of Non- and Minimally Invasive Aesthetic Procedures

      2. 4.2.2 Increasing Awareness among Customers about Cosmetic Procedures

      3. 4.2.3 Availability of User-friendly Aesthetic Products

    3. 4.3 Market Restraints

      1. 4.3.1 Stringent Safety Regulations for Aesthetic Procedures

      2. 4.3.2 Risk of Side Effects

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Product

      1. 5.1.1 Botulinum Toxin

      2. 5.1.2 Dermal Filler

        1. Absorbable Dermal Filler

        2. Non-absorbable Dermal Filler

      3. 5.1.3 Chemical Peel

      4. 5.1.4 Microdermabrasion

    2. 5.2 By End User

      1. 5.2.1 Office Facilities

      2. 5.2.2 Hospitals

      3. 5.2.3 Other End Users


    1. 6.1 Company Profiles

      1. 6.1.1 Allergan PLC

      2. 6.1.2 Bioxis Pharmaceuticals

      3. 6.1.3 Dermaceutic Laboratoire

      4. 6.1.4 Ipsen Pharma

      5. 6.1.5 Johnson & Johnson

      6. 6.1.6 Nestle Skin Health

      7. 6.1.7 Merz Pharma Gmbh & Co. Kgaa

      8. 6.1.8 Laboratoires Filorga

      9. 6.1.9 Teoxane Laboratories

      10. 6.1.10 Laboratories Vivacy

    2. *List Not Exhaustive

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

Related Reports